XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Distributions in Excess of Accumulated Earnings
Total Common Shareholders' Equity
Noncontrolling Interests
Redeemable Non Controlling Interests
Balance at Dec. 31, 2023 $ 2,083,217 $ 95 $ 1,953,521 $ 32,442 $ (349,141) $ 1,636,917 $ 446,300  
Balance (in Shares) at Dec. 31, 2023   95,362,000            
Beginning Balance, Redeemable NCI at Dec. 31, 2023               $ 50,339
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of OP Units to Common Shares by limited partners of the Operating Partnership   $ 1 12,912     12,913 (12,913)  
Conversion of OP Units to Common Shares by limited partners of the Operating Partnership (in Shares)   795,000            
Issuance of Common Shares, net 113,848 $ 7 113,841     113,848    
Issuance of Common Shares (in Shares)   6,987,000            
Dividends/distributions declared (20,021)       (18,568) (18,568) (1,453)  
City Point Loan accrued interest               (2,323)
Employee and trustee stock compensation, net 4,245   202     202 4,043  
Employee and trustee stock compensation, net (in Shares)   12,000            
Capital call receivable (6,153)           (6,153)  
Noncontrolling interest distributions (5,459)           (5,459) 0
Noncontrolling interest contributions 43,709           43,709 0
Net income (6,857)           (7,572)  
Comprehensive income (loss) 10,129     14,500 3,269 17,769 (5,086) (2,554)
Comprehensive income (loss) 12,683              
Reallocation of noncontrolling interests     (2,181)     (2,181) 2,181 [1]  
Balance at Mar. 31, 2024 2,226,069 $ 103 2,078,295 46,942 (364,440) 1,760,900 465,169  
Balance (in Shares) at Mar. 31, 2024   103,156,000            
Ending Balance, Redeemable NCI at Mar. 31, 2024               45,462
Balance at Dec. 31, 2024 $ 2,501,689 $ 120 2,436,285 38,650 (409,383) 2,065,672 436,017  
Balance (in Shares) at Dec. 31, 2024 119,657,594 119,658,000            
Beginning Balance, Redeemable NCI at Dec. 31, 2024 $ 30,583             30,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of OP Units to Common Shares by limited partners of the Operating Partnership     1,718     1,718 (1,718)  
Conversion of OP Units to Common Shares by limited partners of the Operating Partnership (in Shares)   113,000            
Issuance of Common Shares, net 277,506 $ 11 277,495     277,506    
Issuance of Common Shares (in Shares)   11,173,000            
Dividends/distributions declared (27,635)       (26,191) (26,191) (1,444)  
Consolidation of previously unconsolidated investment 29,573           29,573  
City Point Loan accrued interest               (3,017)
Employee and trustee stock compensation, net 2,599   137     137 2,462  
Employee and trustee stock compensation, net (in Shares)   12,000            
Noncontrolling interest distributions (4,799)           (4,799)  
Noncontrolling interest contributions 7,990           7,990  
Net income (11,657)           (11,596)  
Comprehensive income (loss) (25,846)     (11,586) 1,608 (9,978) (14,199) (1,669)
Comprehensive income (loss) (24,177)              
Reallocation of noncontrolling interests     (10,904)     (10,904) 10,904 [1]  
Balance at Mar. 31, 2025 $ 2,762,746 $ 131 $ 2,704,731 $ 27,064 $ (433,966) $ 2,297,960 $ 464,786  
Balance (in Shares) at Mar. 31, 2025 130,955,940 130,956,000            
Ending Balance, Redeemable NCI at Mar. 31, 2025 $ 25,897             $ 25,897
[1] Adjustment reflects the difference between the fair value of the consideration received or paid and the book value of the Common Shares, Common OP Units, Preferred OP Units, and LTIP Units involving changes in ownership.